Study suggests Long Covid could leave you at risk of autoimmune disease one year on
It's been clear since the emergence of Covid that the virus compromises immune functions by attacking white cells that fight infection, but the long-term consequences of this have remained poorly understood. (Source: Daily Express - Health)
Source: Daily Express - Health - September 22, 2022 Category: Consumer Health News Source Type: news
Incident Cardiovascular Disease Risk Up With Autoimmune Disease
FRIDAY, Sept. 16, 2022 -- Individuals with autoimmune disease have an increased risk for developing incident cardiovascular disease, according to a study published online Aug. 27 in The Lancet to coincide with the European Society of Cardiology... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 16, 2022 Category: Pharmaceuticals Source Type: news
Cell-killing cancer therapy shows promise for a devastating autoimmune disorder
Opening a new frontier in fighting autoimmune disease, researchers have successfully treated five lupus patients with a novel cell therapy that turns run-of-the-mill immune cells into specialized hunters of rogue cells helping fuel illness. The patients treated with the new therapy all saw their severe symptoms, including kidney and other organ dysfunction, largely disappear.
The results “are phenomenal,” says Betty Diamond, an immunologist and rheumatologist at the Feinstein Institutes for Medical Research who cares for lupus patients and was not involved in the work. Despite her excitement, she cautions that th...
Source: ScienceNOW - September 15, 2022 Category: Science Source Type: news
Scientists hail autoimmune disease therapy breakthrough
Study finds CAR T-cell treatment sends lupus into remission, raising hopes it could be used to treat diseases such multiple sclerosisFive people with severe autoimmune disease have become the first in the world to receive a groundbreaking therapy that uses genetically altered cells to drive the illness into remission.The four women and one man, aged 18 to 24, received transfusions of modified immune cells to treat severe lupus, an autoimmune disease that can cause life-threatening damage to the heart, lungs, brain and kidneys.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 15, 2022 Category: Science Authors: Ian Sample Science editor Tags: Science Health Genetics Multiple sclerosis Source Type: news
Autoimmune Diseases Linked to Spike in Post-MI Events Autoimmune Diseases Linked to Spike in Post-MI Events
The findings highlight the need for evidence-based screening and management guidelines for cardiovascular disease in these high-risk patients, an observer says.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 15, 2022 Category: Allergy & Immunology Tags: Cardiology News Source Type: news
Dementia warning: The sign in your hair that may raise your risk of dementia 'threefold'
Increasing evidence is supporting a link between autoimmune diseases and the development of cognitive impairment and vascular damage. This connection, researchers believe, may be attributable to similarities in the conditions' inflammatory markers. (Source: Daily Express - Health)
Source: Daily Express - Health - September 15, 2022 Category: Consumer Health News Source Type: news
Rheumatic Diseases and ART Pregnancies: Things to Consider Rheumatic Diseases and ART Pregnancies: Things to Consider
Karmela Kim Chan, MD, and Caroline H. Siegel, MD, MS, give an update on what ' s known about the use of assisted reproductive technology (ART) in patients with autoimmune rheumatic diseases.Hospital for Special Surgery (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - September 14, 2022 Category: Rheumatology Tags: Rheumatology Commentary Source Type: news
Consumer Health: What do you know about these 3 rare rheumatic diseases?
September is Rheumatic Disease Awareness Month, which makes this a good time to learn about three rare rheumatic diseases: Behcet's disease, Churg-Strauss syndrome and Takayasu's arteritis. Behcet's disease Behcet's disease, also called Behcet's syndrome, is a rare disorder that causes blood vessel inflammation throughout your body. The disease may be an autoimmune disorder, which means the body's immune system mistakenly attacks some of its own healthy cells. It's likely that genetic and environmental factors play a… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 14, 2022 Category: Databases & Libraries Source Type: news
Bain, others invest in Nimbus Therapeutics' $125M round. Here's what the CEO had to say.
Nimbus Therapeutics last made headlines in 2016, when the Cambridge-based company sold a drug for the liver disease NASH to Gilead Sciences (Nasdaq: GILD) for a clean $1.2 billion — including $400 million up front. Since then, the company has quietly shifted its focus to autoimmune disease drugs, targeting the skin disorder psoriasis and certain cancers. Nimbus got a boost to those efforts on Monday. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 12, 2022 Category: American Health Authors: Rowan Walrath Source Type: news
Novel Study Offers Clues to Sex Bias in Lupus Incidence Novel Study Offers Clues to Sex Bias in Lupus Incidence
Researchers compared immune cells in cisgender and transgender subjects to investigate the role of sex hormones independently from chromosomes in a study on sex bias in autoimmune disease.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 12, 2022 Category: Dermatology Tags: Rheumatology News Source Type: news
Experimental Drug Shows Promise Against Lupus
THURSDAY, Sept. 8, 2022 -- An experimental drug that has been shown to treat rashes in people with lupus may also help with lupus-related joint pain.
Affecting as many as 1.5 million people in the United States, lupus is an autoimmune disease in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 8, 2022 Category: General Medicine Source Type: news
These Environmental Factors Increase the Risk of IBD
During the past 60 years, experts have documented a steep rise in the incidence of both ulcerative colitis and Crohn’s disease—the two medical conditions that make up most cases of inflammatory bowel disease (IBD). For decades, this rise was confined to North America, Western Europe, and other industrialized nations. While there’s some evidence that the rise in IBD has slowed down or even plateaued in those places, IBD is becoming increasingly common in newly industrialized countries in Asia and other parts of the world.
There’s no question that genetic factors play a part in a person’s risk f...
Source: TIME: Health - September 2, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news
Researchers take aim at cancer drugs ’ toxic side effects
The patient was a success story, his advanced melanoma erased by a popular new cancer treatment. Known as immune checkpoint inhibitors, the drugs coax the immune system to seek and destroy cancer cells—and in this case, they “worked beautifully,” says Kerry Reynolds, an oncologist at Massachusetts General Hospital (MGH) who helped care for the man.
But about a month after an infusion, without a melanoma cell detectable in his body, the 64-year-old was admitted to the hospital, gravely ill. The drugs were sending his immune system into overdrive, wreaking havoc on his colon and nervous system.
Doctors strug...
Source: ScienceNOW - August 31, 2022 Category: Science Source Type: news
Lupus, MS and Other Autoimmune Disorders Raise Heart Risks
WEDNESDAY, Aug. 31, 2022 -- Research has linked heart disease to specific autoimmune diseases such as rheumatoid arthritis and lupus. Now, a huge study shows that autoimmune diseases as a group increase your chances of developing heart... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 31, 2022 Category: General Medicine Source Type: news
Pill to Counter Lupus Shows Promise in Mouse Study
THURSDAY, Aug. 25, 2022 -- An experimental new pill could boost treatment of the autoimmune disease lupus, researchers reported at the American Chemical Society ' s annual meeting.
The pill has been shown in mouse studies to inhibit lupus symptoms,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 25, 2022 Category: General Medicine Source Type: news
